-
Sun Pharma drug combo scoresFDA approval in advanced castration-resistant prostate cancer
pharmafile
May 25, 2018
Sun Pharma is celebrating with the announcement that its CYP17 inhibitor Yonsa (abiraterone acetate) has been awarded FDA approval in combination with methylprednisolone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult
-
Attacking treatment-resistant prostate cancer by blocking its stress response
fiercebiotech
May 03, 2018
Prostate cancer cells rely on protein synthesis to fuel their growth, but there can be too much of a good thing: Prostate tumors that are flooded with protein will actually die.
-
Researchers to investigate screening for prostate cancer using MRI
europeanpharmaceuticalreview
April 09, 2018
A new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accurately…
-
Taking a standard prostate cancer drug with food boosts impact
europeanpharmaceuticalreview
April 04, 2018
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues…
-
USFDA grants priority to XTANDI's sNDA
biospectrumasia
March 21, 2018
When approved, the sNDA would expand the indication of XTANDI to include men with non-metastatic Castration-Resistant Prostate Cancer
-
FDA Grants Priority Review for Prostate Cancer Treatment
biospace
March 21, 2018
Pfizer and Astellas Pharmaceuticals Say to Apply for Supplementary New Drugs for US Food and Drug Administration
-
NHS trials "world-leading" initiative to cut prostate cancer diagnoses to just days
pharmafile
March 06, 2018
The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than one week by trialling a “world-leading” approach which leverages a new, more accurate scanning method.
-
Brexit may disrupt medicines supply, warns British alliance
pharmaceutical-technology
January 31, 2018
The alliance cited an example that around 120,000 prostate cancer patients across Europe might be affected if Brexit negotiations fail to secure a future collaboration on regulation and trade of medicines and medical devices.
-
Dietary fat, changes in fat metabolism may promote prostate cancer metastasis
europeanpharmaceuticalreview
January 17, 2018
Researchers have shed new light on the genetic mechanisms that promote metastasis and implicated the typical Western high-fat diet as a key environmental factor…
-
Tapeworm drug fights prostate cancer
europeanpharmaceuticalreview
November 17, 2017
A Norwegian study shows that NTZ contains a substance that can kill prostate and colon cancer…
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
